Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
67 studies found for:    "Chronic Fatigue Syndrome"
Show Display Options
Rank Status Study
1 Completed B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome
Conditions: Chronic Fatigue Syndrome;   Myalgic Encephalomyelitis
Intervention: Drug: Rituximab
2 Completed The Study of the Safety and Efficacy of Ampligen in Chronic Fatigue Syndrome
Conditions: Chronic Fatigue Syndrome;   Myalgic Encephalomyelitis
Intervention: Drug: Ampligen
3 Terminated Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome
Conditions: Chronic Fatigue Syndrome;   Myalgic Encephalomyelitis
Intervention: Drug: Etanercept
4 Recruiting B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Very Severe Chronic Fatigue Syndrome
Conditions: Chronic Fatigue Syndrome;   Myalgic Encephalomyelitis
Intervention: Drug: Rituximab
5 Active, not recruiting The Synergy Trial: Methylphenidate Plus a CFS-Specific Nutrient Formula as a Treatment for Chronic Fatigue Syndrome
Conditions: Chronic Fatigue Syndrome (CFS);   Myalgic Encephalomyelitis (ME)
Interventions: Drug: Methyl-P plus Nutrient Formula;   Drug: Methyl-P plus Nutrient matched placebos
6 Completed The Norwegian Study of Chronic Fatigue Syndrome in Adolescents: Pathophysiology and Intervention Trial
Conditions: Chronic Fatigue Syndrome;   Myalgic Encephalomyelitis
Interventions: Drug: Clonidine;   Drug: Lactose capsula
7 Unknown  Chronic Fatigue Syndrome: A Presumptive Mitochondrial Disorder
Condition: Chronic Fatigue Syndrome
Interventions: Drug: Nutraceutical supplements;   Drug: Placebo
8 Completed Drug Intervention in Chronic Fatigue Syndrome
Condition: Chronic Fatigue Syndrome
Interventions: Drug: Rituximab;   Drug: Saline (NaCl 0,9 %) (placebo)
9 Recruiting Cytokine Inhibition in Chronic Fatigue Syndrome Patients
Condition: Chronic Fatigue Syndrome
Interventions: Drug: Anakinra;   Drug: Placebo
10 Active, not recruiting Autonomic Nervous System and Chronic Fatigue Syndrome
Conditions: Chronic Fatigue Syndrome;   Orthostatic Intolerance;   Postural Tachycardia Syndrome
Interventions: Other: Autonomic Function Testing;   Other: Saline infusions;   Drug: L-NMMA trimethaphan;   Drug: methyldopa
11 Completed Treatment of Chronic Fatigue Syndrome and Fibromyalgia With D-ribose- a Multicenter Study
Conditions: Fibromyalgia;   Chronic Fatigue Syndrome
Intervention: Dietary Supplement: Ribose
12 Active, not recruiting Coping With Chronic Fatigue Syndrome: Development of a Community-based Patient Education Program
Conditions: Chronic Fatigue Syndrome;   Coping;   Patient Education
Intervention: Behavioral: Patient education program
13 Unknown  Acupuncture for the Sleep Disorder of Chronic Fatigue Syndrome
Condition: Chronic Fatigue Syndrome
Interventions: Device: Acupuncture;   Device: Sham acupuncture
14 Recruiting Study of Ampligen in Chronic Fatigue Syndrome
Condition: Chronic Fatigue Syndrome
Intervention: Drug: Poly I: Poly C12U
15 Completed Therapy for Chronic Fatigue Syndrome: A Presumptive Mitochondrial Disorder
Condition: Chronic Fatigue Syndrome
Intervention: Drug: Nutraceuticals
16 Completed Epstein-Barr Virus as a Possible Cause for Chronic Fatigue Syndrome
Condition: Chronic Fatigue Syndrome
Intervention:
17 Terminated Use of Xyrem to Improve Sleep in Chronic Fatigue Syndrome
Condition: Chronic Fatigue Syndrome
Intervention: Drug: Xyrem [sodium oxybate]
18 Recruiting Observational Research on Use of Immunoprop Supplement in Chronic Fatigue Syndrome
Condition: Chronic Fatigue Syndrome
Intervention:
19 Terminated
Has Results
Study To Assess The Clinical Benefit Of Droxidopa In Subjects With Chronic Fatigue Syndrome
Conditions: Chronic Fatigue Syndrome;   Orthostatic Hypotension;   Neurally Mediated Hypotension;   Neurogenic Orthostatic Hypotension
Intervention: Drug: Droxidopa
20 Completed
Has Results
Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Chronic Fatigue Syndrome
Conditions: Chronic Fatigue Syndrome;   Cognitive Impairments
Interventions: Drug: Lisdexamfetamine Dimesylate;   Drug: Placebo "30, 50 or 70 mg"

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years